                         SEQUENCE LISTING

<110>  Gavish-Galilee Bio Applications, Ltd.
 
<120>  COMBINATION THERAPIES INCLUDING HUMAN CHITINASE (CHIT1), AND 
       IMPROVED CHIT1 FOR THE TREATMENT OF SYSTEMIC FUNGAL INFECTION

<130>  GAVISH-072 PCT

<140>  USSN 62/413,618
<141>  2016-10-27

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  445
<212>  PRT
<213>  human

<400>  1

Met Lys Leu Val Cys Tyr Phe Thr Asn Trp Ala Gln Tyr Arg Gln Gly 
1               5                   10                  15      


Glu Ala Arg Phe Leu Pro Lys Asp Leu Asp Pro Ser Leu Cys Thr His 
            20                  25                  30          


Leu Ile Tyr Ala Phe Ala Gly Met Thr Asn His Gln Leu Ser Thr Thr 
        35                  40                  45              


Glu Trp Asn Asp Glu Thr Leu Tyr Gln Glu Phe Asn Gly Leu Lys Lys 
    50                  55                  60                  


Met Asn Pro Lys Leu Lys Thr Leu Leu Ala Ile Gly Gly Trp Asn Phe 
65                  70                  75                  80  


Gly Thr Gln Lys Phe Thr Asp Met Val Ala Thr Ala Asn Asn Arg Gln 
                85                  90                  95      


Thr Phe Val Asn Ser Ala Ile Arg Phe Leu Arg Lys Tyr Ser Phe Asp 
            100                 105                 110         


Gly Leu Asp Leu Asp Trp Glu Tyr Pro Gly Ser Gln Gly Ser Pro Ala 
        115                 120                 125             


Val Asp Lys Glu Arg Phe Thr Thr Leu Val Gln Asp Leu Ala Asn Ala 
    130                 135                 140                 


Phe Gln Gln Glu Ala Gln Thr Ser Gly Lys Glu Arg Leu Leu Leu Ser 
145                 150                 155                 160 


Ala Ala Val Pro Ala Gly Gln Thr Tyr Val Asp Ala Gly Tyr Glu Val 
                165                 170                 175     


Asp Lys Ile Ala Gln Asn Leu Asp Phe Val Asn Leu Met Ala Tyr Asp 
            180                 185                 190         


Phe His Gly Ser Trp Glu Lys Val Thr Gly His Asn Ser Pro Leu Tyr 
        195                 200                 205             


Lys Arg Gln Glu Glu Ser Gly Ala Ala Ala Ser Leu Asn Val Asp Ala 
    210                 215                 220                 


Ala Val Gln Gln Trp Leu Gln Lys Gly Thr Pro Ala Ser Lys Leu Ile 
225                 230                 235                 240 


Leu Gly Met Pro Thr Tyr Gly Arg Ser Phe Thr Leu Ala Ser Ser Ser 
                245                 250                 255     


Asp Thr Arg Val Gly Ala Pro Ala Thr Gly Ser Gly Thr Pro Gly Pro 
            260                 265                 270         


Phe Thr Lys Glu Gly Gly Met Leu Ala Tyr Tyr Glu Val Cys Ser Trp 
        275                 280                 285             


Lys Gly Ala Thr Lys Gln Arg Ile Gln Asp Gln Lys Val Pro Tyr Ile 
    290                 295                 300                 


Phe Arg Asp Asn Gln Trp Val Gly Phe Asp Asp Val Glu Ser Phe Lys 
305                 310                 315                 320 


Thr Lys Val Ser Tyr Leu Lys Gln Lys Gly Leu Gly Gly Ala Met Val 
                325                 330                 335     


Trp Ala Leu Asp Leu Asp Asp Phe Ala Gly Phe Ser Cys Asn Gln Gly 
            340                 345                 350         


Arg Tyr Pro Leu Ile Gln Thr Leu Arg Gln Glu Leu Ser Leu Pro Tyr 
        355                 360                 365             


Leu Pro Ser Gly Thr Pro Glu Leu Glu Val Pro Lys Pro Gly Gln Pro 
    370                 375                 380                 


Ser Glu Pro Glu His Gly Pro Ser Pro Gly Gln Asp Thr Phe Cys Gln 
385                 390                 395                 400 


Gly Lys Ala Asp Gly Leu Tyr Pro Asn Pro Arg Glu Arg Ser Ser Phe 
                405                 410                 415     


Tyr Ser Cys Ala Ala Gly Arg Leu Phe Gln Gln Ser Cys Pro Thr Gly 
            420                 425                 430         


Leu Val Phe Ser Asn Ser Cys Lys Cys Cys Thr Trp Asn 
        435                 440                 445 


